Asomugha C O, Gupta R, Srivastava O P
Department of Vision Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Mol Vis. 2011;17:2407-20. Epub 2011 Sep 14.
The purpose of the study was to determine the relative effects of deamidation and/or truncation on the structural and functional properties of αB-crystallin.
Using wild-type (WT) αB-crystallin and the αB deamidated mutant (i.e., αB N146D), we generated NH(2)-terminal domain deleted (residues no. 1-66; αB-NT), deamidated plus NH(2)-terminal domain deleted (αB N146D-NT), COOH-terminal extension deleted (residues no. 151-175; αB-CT), and deamidated plus COOH-terminal extension deleted (αB N146D-CT) mutants. All of the proteins were purified and their structural and functional (chaperone activity with insulin as target protein) properties were determined and compared to WT αB-crystallin.
The desired deletions in the αB-crystallin mutants were confirmed by DNA sequencing and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometric analysis. The homomers of αB-CT and its deamidated form (αB N146D-CT) became water insoluble, whereas the αB N146D, αB-NT, and αB N146D-NT species remained water-soluble. CD spectroscopic studies revealed that the mutants with deletion of NH(2)- or COOH-termini or deamidation showed increased β-sheet and decreased α-helical contents with the exception of αB N146D-CT, which showed a substantial increase in α-helix and decrease in β-sheet content. Results of intrinsic Trp fluorescence suggested little change in Trp microenvironment of αB N146D relative to WT αB, but substantial alterations on deletion of COOH-terminal extension or a combination of this deletion plus deamidation. Hydrophobic binding studies using the hydrophobic probe 8-anilino-1-naphthalene sulfonate (ANS) showed that, relative to WT αB structure, the N146 deamidation, COOH-terminal extension deletion or a combination of this deamidation and deletion resulted in a relatively compact structure whereas the NH(2)-terminal domain deletion and a combination of this deletion plus deamidation resulted in a relaxed structure. All the αB mutants showed higher molecular mass ranging between 1.2×10(6) to 5.4×10(6) Da, relative to WT αB which had a molecular mass of 5.8×10(5) Da. Chaperone activity across all αB species decreased in the following order: WTαB > αB N146D-CT > αB N146D-NT > αB-NT > αB-CT > αB N146D. Specifically, substantial losses in chaperone activity (only 10% to 20% protection) were seen in αB N146D, αB-NT, and αB-CT. However, in the species with the combination of deamidation plus NH(2)- or COOH-terminal deletion, the percent protection was about 24% in αB N146D-NT and about 40% in αB N146D-CT.
Although all mutants formed oligomers even after deamidation, on deletion of either NH(2)-terminal domain or COOH-terminal extension or a combination of these deletions and deamidation, their structural properties were substantially altered. The results suggested that the NH(2)-terminal domain is relatively more important than the COOH-terminal extension for the chaperone function of αB. The non-deamidated N146 residue, NH(2)-terminal domain and COOH-terminal extension are also of critical importance to the maintenance of αB-crystallin chaperone activity.
本研究旨在确定脱酰胺和/或截短对αB-晶状体蛋白结构和功能特性的相对影响。
利用野生型(WT)αB-晶状体蛋白和αB脱酰胺突变体(即αB N146D),我们构建了氨基末端结构域缺失(第1-66位残基;αB-NT)、脱酰胺加氨基末端结构域缺失(αB N146D-NT)、羧基末端延伸缺失(第151-175位残基;αB-CT)以及脱酰胺加羧基末端延伸缺失(αB N146D-CT)的突变体。所有蛋白质均经纯化,并测定其结构和功能(以胰岛素为靶蛋白的伴侣活性)特性,然后与野生型αB-晶状体蛋白进行比较。
通过DNA测序和基质辅助激光解吸/电离飞行时间(MALDI-TOF)质谱分析证实了αB-晶状体蛋白突变体中所需的缺失。αB-CT及其脱酰胺形式(αB N146D-CT)的同聚物变得不溶于水,而αB N146D、αB-NT和αB N146D-NT仍可溶于水。圆二色光谱研究表明,氨基或羧基末端缺失或脱酰胺的突变体β-折叠含量增加,α-螺旋含量降低,但αB N146D-CT除外,其α-螺旋含量大幅增加,β-折叠含量降低。内源色氨酸荧光结果表明,相对于野生型αB,αB N146D的色氨酸微环境变化不大,但羧基末端延伸缺失或该缺失与脱酰胺组合时会发生显著改变。使用疏水探针8-苯胺基-1-萘磺酸盐(ANS)的疏水结合研究表明,相对于野生型αB结构,N146脱酰胺、羧基末端延伸缺失或该脱酰胺与缺失的组合导致结构相对紧密,而氨基末端结构域缺失以及该缺失与脱酰胺的组合导致结构松弛。所有αB突变体的分子量均高于野生型αB,野生型αB的分子量为5.8×10⁵ Da,而突变体的分子量在1.2×10⁶至 5.4×10⁶ Da之间。所有αB物种的伴侣活性按以下顺序降低:WTαB > αB N146D-CT > αB N146D-NT > αB-NT > αB-CT > αB N146D。具体而言,αB N146D、αB-NT和αB-CT的伴侣活性大幅降低(仅10%至20%的保护作用)。然而,在脱酰胺加氨基或羧基末端缺失组合的物种中,αB N146D-NT的保护百分比约为24%,αB N146D-CT约为40%。
尽管所有突变体即使在脱酰胺后仍形成寡聚体,但氨基末端结构域或羧基末端延伸缺失或这些缺失与脱酰胺的组合会使其结构特性发生显著改变。结果表明,对于αB的伴侣功能,氨基末端结构域比羧基末端延伸相对更重要。未脱酰胺的N146残基、氨基末端结构域和羧基末端延伸对维持αB-晶状体蛋白的伴侣活性也至关重要。